Understanding the Rarity of This Disease
Anaplastic large cell lymphoma, often shortened to ALCL, represents a very small portion of all cancer cases. It accounts for approximately 2% of all adult non-Hodgkin lymphoma diagnoses, making it genuinely rare in the broader landscape of cancers[2]. Within the category of T-cell lymphomas specifically, ALCL makes up about 24% of peripheral T-cell lymphoma cases in the United States[7]. These numbers help put into perspective just how uncommon this condition is, which also means that not every doctor will have extensive experience treating it, making specialized care particularly important.
The disease has only been well characterized for about two decades, despite being recognized in 1985 when researchers discovered that tumor cells could be identified using a specific antibody marker[3][4]. This relatively recent understanding means that research is still uncovering new information about how the disease works and how best to treat it. The scientific community continues to learn more about this rare condition with each passing year.
Who Gets This Disease
One of the most striking features of ALCL is that it affects different age groups depending on the specific type. ALK-positive ALCL, which means the cancer cells produce a protein called anaplastic lymphoma kinase, is more common in children and adolescents. This form is notably more frequent in the first three decades of life, meaning it often strikes young people, pre-teens, teenagers, and adults in their 20s and 30s[1][2]. On the other hand, ALK-negative ALCL, where cancer cells do not produce this protein, primarily affects older adults, particularly those over 60 years of age[2].
Gender also plays a role in who develops this disease. Overall, ALCL shows a male predominance, with a male to female ratio of approximately 1.5 to 1[1][4]. This means that men are somewhat more likely to develop the condition than women. The ALK-positive form is significantly more common in men, while the ALK-negative type is only slightly more common in males[2]. Understanding these patterns helps doctors know which patients might be at higher risk and need closer monitoring.
What Causes This Cancer
The origins of ALCL are not completely understood, though researchers have identified several important connections. ALCL of the ALK-positive type usually originates from T cells, which are white blood cells that help the body fight infections[1]. The disease can be primary, meaning it starts on its own, or secondary, meaning it develops after another condition. Some cases have been associated with HIV infection, a skin condition called mycosis fungoides, and certain lung conditions called inflammatory pseudotumors[1].
Interestingly, other than in breast implant-associated ALCL, there are no known specific risk factors for developing this disease[6]. This means doctors cannot yet identify lifestyle changes, environmental exposures, or genetic markers that would clearly predict who will develop ALCL. The lack of identifiable risk factors makes prevention strategies difficult to design, and it also means that people who develop this cancer should not blame themselves, as there was likely nothing they could have done differently to prevent it.
Common Signs and Symptoms
The symptoms of ALCL vary depending on where the cancer is located in the body, but many patients share certain common experiences. Most people diagnosed with ALCL present with advanced-stage disease, meaning the cancer has already spread to multiple areas by the time it is detected. Stage III or IV disease is common at diagnosis, which indicates the lymphoma has affected lymph nodes on both sides of the diaphragm or has spread to organs outside the lymph system[1].
Many patients experience what doctors call B symptoms, which is a specific group of symptoms that includes persistent fevers, unintentional weight loss, and profuse night sweats that soak through clothing and bedsheets[1]. These symptoms occur because the cancer affects the body’s metabolism and immune system, causing the body to respond with fever and excessive sweating. The weight loss happens because the body is using energy to fight the disease and because appetite often decreases.
The disease frequently involves both lymph nodes (small bean-shaped organs that filter fluid and fight infection) and extranodal sites (areas outside the lymph nodes)[5]. The most commonly affected extranodal sites include the skin, bone, soft tissue, lungs, and liver[5]. When the skin is involved, patients might notice unusual bumps, rashes, or skin changes. Some patients may also develop high fevers as a particularly prominent symptom[5]. Involvement of the gastrointestinal system and central nervous system is rare but can occur[5]. Bone marrow involvement occurs in approximately 10-30% of cases, depending on which tests doctors use to check for it[5].
Prevention Possibilities
Because there are no known risk factors for most forms of ALCL, there are no established prevention strategies for the general population. Unlike cancers linked to smoking, diet, or sun exposure, ALCL develops without clear environmental or lifestyle triggers that people could avoid. This absence of preventive measures can feel frustrating for patients and their families who wish they could have done something to prevent the disease.
The one exception involves breast implant-associated ALCL, which has been linked to breast implants, particularly those with textured surfaces[4][2]. This form is usually diagnosed about 10 years after breast augmentation or reconstruction surgery[2]. Women considering breast implants can discuss with their doctors the differences between textured and smooth implants and weigh the extremely small risk of developing this rare cancer against the benefits of the procedure. However, it’s crucial to understand that even with textured implants, the risk remains extremely low.
How the Disease Changes Normal Body Function
At its core, ALCL involves the abnormal growth of T-lymphocytes, which are white blood cells normally responsible for protecting the body from infections and diseases. In healthy individuals, T-lymphocytes travel through the lymphatic system, identifying and attacking harmful invaders like viruses and bacteria. When ALCL develops, these T-lymphocytes undergo changes that cause them to multiply uncontrollably and fail to perform their normal protective functions.
The disease is characterized by large pleomorphic (varied in shape) lymphoid cells with abundant cytoplasm (the gel-like substance inside cells) and distinctive horseshoe-shaped nuclei (the control centers of cells)[1]. When doctors examine these cells under a microscope, they see characteristic “hallmark” cells that have these horseshoe or wreath-like nuclei, multiple nucleoli (structures within the nucleus), and other unusual features[1]. These hallmark cells are present in all morphological variants of ALCL, making them an important diagnostic feature.
The cells strongly express a marker called CD30, which is a protein found on the surface of the cancer cells[1][7]. This CD30 expression is constant across all ALCL cases and helps doctors distinguish this lymphoma from others. In ALK-positive cases, the disease involves a chromosomal translocation, which means two chromosomes have broken and swapped pieces. Specifically, there is a t(2;5) translocation involving the ALK gene and a gene called nucleophosmin (NPM1)[1]. This genetic rearrangement causes the cells to produce abnormal proteins that drive the cancer’s growth.
As these abnormal cells accumulate, they infiltrate lymph nodes and can spread to other organs. The infiltration disrupts the normal architecture of these organs, preventing them from functioning properly. In lymph nodes, the cancer cells fill the spaces where normal immune cells would reside, impairing the body’s ability to fight infections. When the disease spreads to organs like the liver, lungs, or bone, it can interfere with those organs’ specific functions, leading to various symptoms depending on which organs are affected.
